program - d2cax41o7ahm5l.cloudfront.net€¦ · quintiles, inc. usa raymond huml vice precident...
TRANSCRIPT
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Conference Secretariat2360 Corporate Circle, Suite 400 Henderson
NV 89074-7722, USAConference Series
Direct: (702) 508-5200 Ext: 8083Tel: +1 (800) 216 6499
Email: [email protected]
Program
August 10-12, 2017 Beijing, China
8th Asian Biologics and Biosimilars CongressExpert Speakers. Evidence based. Health Care Professionals.
Seating is LimitedRegister Today!
Dear Colleagues, Scientists and Friends,
The Organizing Committee is delighted to invite you to attend the 8th Asian Biosimilars Congress, one of its remarkable pharmaceutical conferences, to be held during August 10-12, 2017 in Beijing, China. The Asian Biosimilars Congress 2017 brings together scientists, researchers, industry and CRO representatives from around the world.
As of December 2016 there were 23 biosimilars marketed in the EU and 4 biosimilars licensed in the USA. As such, the biosimilars market is expected to experience an exponential growth over the coming few years. Many new biologics are making their entry in the pharma market and experiencing a notable rise in their usage compared with the conventional medications.
The 8th Asian Biosimilars Congress will present multiple aspects of biosimilars from the passage of biosimilars through a decade in Asia to the latest developments in the field of biologics and biosimilars. The whole range of portfolio selection, development, regulatory requirements and marketing will be presented.
You can join your peers from around the world focused on learning about biologics and biosimilars-related advances, which is your single best opportunity to reach the largest assembly of participants from the Biosimilars community, conduct demonstrations, distribute information, meet with professionals, make a splash with new research, and receive name recognition at this 3-day event.
The congress will provide enough space for discussion, meetings and workshops in order to allow a close contact between speakers and visitors.
We are looking forward to see you in Beijing, China
Raymond Huml, MS, DVM, RAC, QuintilesIMSOxana Iliach, PhD, QuintilesIMS
Charu Manaktala, MD, QuintilesIMS
Welcome Message
Dear Industry Colleagues, Scientists and Friends,
As a member of the Organizing Committee I am delighted to invite you to attend the 8th Asian Biologics and Biosimilars Congress to be held from August 10-12, 2017 in Beijing, China. The Asian Biosimilars Congress 2017 brings together biopharmaceutical industry colleagues, scientists, researchers, regulatory, and clinical experts from around the globe to bring to you the cutting edge information for the development of biosimilars.
The 8th Asian Biologics and Biosimilars Congress is designed to bring forth the most up to date information for the development of biosimilars. Key aspects will include regulatory, CMC, clinical and marketing considerations, as they relate to what it will take to bring these lifesaving/life altering products to the highly regulated Western Markets.
Please join your peers from around the world for this wonderful opportunity to reach the largest assembly of participants from the Biologics/Biosimilars community, meet with thought leadership experts, share your new research, and show off your cutting edge technology at this 3-day event.
I look forward to seeing you in Beijing, China at the 8th Asian Biologics and Biosimilars Congress.
Kamali ChanceMPH, PhD, RAC
Vice President Head, Global Biosimilars Regulatory Strategy
Biosimilars Center of Excellence QuintilesIMS
Welcome Message
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Confreence Highlights•LatestBiosimilarsinAsianScenario•Biosimilars-Hatch-WaxmanAct&BPCIAct•ChallengesinDevelopingBiosimilars•BiosimilarsResearchPipeline•CurrentDevelopmentsinTheFieldofBiosimilars•PharmacovigilanceofBiosimilars•EmergingTrendsinBiosimilars•BiosimilarsMarket-Challenges&Prospects•CostAnalysisofBiosimilars•GlobalizationofBiosimilars•BiosimilarsAnalyticalStrategies•EmergingBiosimilarsinTherapeutics•ClinicalStudiesonBiosimilars•BCS&IVIVCBasedBiowaivers•EntrepreneursInvestmentMeet
** Speaker Slots are Available **
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Organizing Committee Members
Oxana IliachSr. Director
Quintiles IMSCanada
Kamali ChanceVice PresidentQuintiles, Inc.
USA
Raymond HumlVice PrecidentQuintiles IMS
USA
Hossein PakdamanShahid Beheshti University
of Medical SciencesTehran, Iran
Candida FratazziPresident
BBCR ConsultingUSA
Charu ManaktalaSenior Medical Director
Quintiles IMSIndia
Lutz HilbrichHead of Biosimilars
Platform in China Shanghai, China
Asif MahmoodDisease Area Cluster
Lead for Biosimilars PfizerUSA
Osama O. IbrahimConsultant Biotechnology/
Food SafetyBioinnovation, USA
Suzette DiMascioCEO & President
CSI Specialty GroupUSA
Jianguo YangPresident / CEO Abpro
China DivisionUSA
T. Santha RajuSr. Director & Head
MedImmuneUSA
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Top Participating Organisations
August 10-12, 2017 Beijing, China
8th Asian Biologics and Biosimilars Congress
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
KeynoteForumsTitle:FDA/EMACurrentThinkingonTotalityofEvidenceforDevelopmentofBiosimilarsKamaliChance,VicePresident,Head,GlobalBiosimilarsRegulatoryStrategy,BiosimilarsCenterofExcellence,Quintiles,Inc.,USATitle:Biosimilars:AcceleratingEarlyClinicalDevelopmentRaymondHuml,VicePrecident,QuintilesIMS,USATitle:StrategyfortheGlobalDevelopmentofBiosimilars:puttingit’salltogetherOxanaIliach,Sr.Director,QuintilesIMS,CanadaTitle:StrategicPartnershipforChinaBiologicsJianguoYang,President/CEO,AbproChinaDivision,USATitle:ClinicalDevelopmentofBiosimilarsforWesternMarkets:PlanningforSuccessCharuManaktala,SeniorMedicalDirector,QuintilesIMS,IndiaTitle:BiosimilarsintreatmentofmultiplesclerosisinIranHosseinPakdaman,PresidentofIranianNeurologicalAssociation,Iran
SpecialSessionsTitle:Biosimilars:ChallengesinSafetyandRiskManagementAsifMahmood,DiseaseAreaClusterleadforBiosimilars,Pfizer,USA
ScientificSessionsTitle:UpdateonbiosimilarslitigationintheU.S.:Whatifyoudon’twanttodance?GeorgeC.Yu,J.D.,M.S.,SchiffHardinLLP,USATitle:ChallengesinAssessingTherapeuticEquivalenceofNano-SimilarsBeatFlühmann,DirectorViforPharmaLtd,SwitzerlandTitle:BiosimilarGlobalization-Asilverlininginuntestedwaters!BiosimilarsinChina:balanceofrisksandopportunities.CandidaFratazziMD,President,BBCRConsulting,USATitle:TheroleofregulatorypoliciesinrelationtothelocalbiosimilarsproductionGustavoH.Marin,PhD,UNLP-CONICET,ArgentinaTitle:PracticalConsiderationsinClinicalStrategytoSupporttheDevelopmentofBiologicsDeviceCombinationProductsZhaoyangLi,Director,Sanofi,USATitle:ExpressionofwithShigaliketoxin(SLT)fusedtovascularendothelialgrowthfactor(VEGF)inEcolifortargetingangiogenesisOsamaO.IbrahimPh.D.,ConsultantBiotechnology,BioInnovationLLC,USATitle:MedicinesdistributionsandfinancingalternativesAbdeenMOmer,PhD,Khartoum,SudanTitle:SomeConsiderationsaboutBiosimlarSafetySamerM.Al-Hulu,PhD,Al-QasimGreenUniversity,IraqTitle:ThestudyofAntimicrobialandanti-Alzheimer'seffectsofturmericextractbasedonamyloidnano-bio-fibrilsformationinhibitionmethodAmirArasteh,AssistantProfessorofBiochemistry,Departmentofbiology,RashtBranch,IslamicAzadUniversity,Rasht,IranTitle:EvaluationTheCytotoxicityOfAnOscillatoriaSp.ExtractOnBreastCancerCellLine(Mcf-7)AndAssessmentOfNoxaGeneExpressionAliSalehzadeh,DepartmentofBiology,RashtBranch,IslamicAzadUniversity,Rasht,IranTitle:SignificanceofstabilityandtemperatureexcursionstudiesforBiologisticsRajivDua,SiteATSHead,SunPharmaceuticalsLtd,IndiaTitle:GlobalStatusofBiosimilars&ProspectsinAsiaMdAbuZaforSadek,InstituteofBusinessAdministration,UniversityofDhaka,BangladeshTitle:Bioassay-DirectedIsolationOfHypotensiveAlkaloidsFromHolarrenaPubescensAftabKhalid,H.E.J.ResearchInstituteofChemistry,UniversityofKarachi,PakistanTitle:HeterogeneityofMonoclonalAntibodyandChallengesinDevelopingBiosimilarofitSunitMaity,PhD,Zumutor,India
SpeakerSlotsAvailableNOTE:Programissubjecttochangewithfinalallotmentofthespeakerslots
Tentative Program
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Previous Speakers
Patrick LucyPfenex Inc. , USA
Milind AntaniNishith Desai
Associates, India
Gregory J GloverPharmaceutical Law
Group PC, USA
Mark A. EmalfarbDyadic
International, Inc. USA
Alex BrillMatrix Global Advisors , USA
William A. SarrailleSidley Austin LLP
USA
Christopher J LeintzPfizer, Inc, USA
Vivek Kumar MoryaInha University,
Republic of Korea. South Korea
Jill A. MyersMomenta
Pharmaceuticals, USA
Timothy J SheaSterne, Kessler, Goldstein & Fox
P.L.L.C , USA
Subir RoyDGM- Marketing & Medical
at Zydus Cadila, India
Abdel Halim HarrathKing Saud University
Saudi Arabia
Jenny ChenWolf, Greenfield &
Sacks, P.C , USA
Denise M KettelbergerSunstein Kann Murphy & Timbers LLP, USA
Sunit MaityTheramyt Novobiologics
Pvt. Ltd., India
Neil SchauerAvaxia Biologics
USA
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Previous Speakers
Sarfaraz K. NiaziTheraProteins, USA
James Harris IIIHealthcare
Economics LLC, USA
Abe HershkovitzHershkovitz &
Associates, PLLC, USA
Andreu SoldevilaCEO LeanBioPro
Spain
Angela FurlanettoDimock Stratton LLP
Canada
Lisa MuellerMichael Best &
Friedrich LLP, USA
Nigel J RulewskiQuintiles, Inc., USA
Tom CarverWragge Lawrence Graham & Co, UK
Ronald A RaderBiotechnology
Information Institute, USA
Raj DavePillsbury Winthrop Shaw
Pittman, LLP, USA
András GuttmanUniversity of
Pannonia,Hungary SCIEX, USA
Christoph VolpersSenior Patent Consultant
at Michalski & Hüttermann, Germany
Raymond A HumlQuintiles, Inc., USA
Kerisha A. BowenDentons US LLC, USA
Sumant ChaubeyBills Biotech, India
Wolfgang A. RehmannTaylor Wessing
Germany
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Previous Speakers
Marcus MreyenProtagen Protein Services
GmbH, Germany
Alan L. EpsteinUSC Keck School of
Medicine, USA
Adetunji OlawaleOsun State Polytechnic
Nigeria
Samantha LittleCovance Laboratories
Ltd, UK
Min ZhangFujifilm Diosynth Biotechnologies
USA
Upendra NagaichAmity Institute of Pharmacy, India
Afshin SafaviBioAgilytix, USA
Kamali ChanceQuintiles Inc., USA
Fiona M GreerSGS Life Sciences
Switzerland
Gene M. Ransom, IIIUniversity of Maryland and
University of Baltimore School of Law, USA
Mariana BabayevaTouro College Of Pharmacy
USA
Mario DiPaolaBlue Stream Laboratories,
Inc., USA
Volker SchellenbergerAmunix Operating Inc.
USA
Gordon T. BolgerNucro-Technics
Canada
Andy UpsallBioOutsource, UK
Francesco MarchesiRegina Elena National Cancer Institute, Italy
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Previous Speakers
Candida FratazziBBCR Consulting, USA
Krishna MenonCellceutix
Corporation, USA
Daniel GalbraithBioOutsource Ltd, UK
Siddhartha RoyCSIR - Indian Institute of Chemical Biology, India
Noelle SunstromNeuclone PTY LTD
Australia
Dipti GulatiPJI Biotech, USA
Alexander PittersKaiser Optical Systems
France
Laszlo EndrenyiUniversity of Toronto
Canada
Christina VesselyBiologics Consulting, USA
Ruideger JanwoskyCinfa Biotech GmbH
Germany
Christelle DagoneauCatalent Biologics
USA
Aparna KasinathSyngene International
India
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Why to Attend???JoinyourpeersaroundtheworldfocusedonlearningaboutBiologicsandBiosimilarsrelatedadvances,whichisyoursinglebestopportunitytoreachthelargestassemblageofparticipantsfromtheBiosimilarscommunity,conductdemonstrations,distributeinformation,meetwithcurrentandpotentialprofessionals,makeasplashwithanewresearchworks,andreceivenamerecognitionatthis3-dayevent.World-renownedspeakers,themost recent research, advances, and thenewestupdates inBiologicsandBiosimilarsarehallmarksof thisconference.
AtAsianBiosimilars2017meetyourtargetaudiencesfromaroundtheworldfocusedonlearningaboutbiologicsandbiosimilars.Thisconferencewouldbeyoursinglebestopportunitytoreachthe largestassemblageofparticipantsfromthebiologicsandbiosimilarscommunity.
Abstract Information: Oral / Poster Presentation GuidelinesOralPresentationsaregenerallysplitintoTWOcategories,asfollows:
1.PlenaryLectures• EachPlenarylectureis25minutesinlengthandcomprisesonepresentation.Werecommendyouplantopresentforapproximately20minuteswith5minutesforquestions/discussion.
• WherePlenaryLectures arepresentedasdebates, eachof two speakers shouldplan topresent for20minutes,allowingfiveminutesforclosingquestionsandconclusions.WerecommendthatinvitedspeakerscommunicateinadvanceoftheModeratorsothatpresentationsmaybecoordinated.
2.OralSessions• EachOral Session is 60minutes in length and comprises two presentations, of 30minutes each. Werecommendthatyouplantopresentforapproximately15minutes,allowingtimeforquestions/discussionattheendofthepresentation.
Pleaseprepareyoupresentationin16:9format(screenareinformat16:9).WerecommendyoutosaveyourPowerPointpresentationusingPPT(X)formatinsteadofPPS.
Atechnicianisavailableineverysessionroomtoprovideassistancewhenneeded.Duetotheonlinepresentationsystem,allspeakersarekindlyrequestedtouseprovidedPConsite.Pleasebepresentinthesessionroom15minutespriorthestartofyoursessionandfollowtheinstructionsfromtheChairsand/ortechnician.Duringyour presentation a remote controlwill be available for controlling your presentation. Please observe thetimeallottedtoyouasyouwillnotbepermittedtospeakfor longertime.AttheendoftheCongress,allpresentationswillbedeletedfromthepresentationsystemandcomputerson-site.
SpeakerPreviewRoom
AllspeakersareaskedtouploadtheirpresentationattheSpeakerPreviewRoom(locatedintheRegistrationarea)atleastonehourbeforethebeginningofthesessionorthedaybeforeincaseofamorningsession.
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Poster GuidelinesTheposterexhibitionwillbeanintegralpartofMedPharmaCongress.
Theposterexhibitionwillbelocatedontheexhibitionareaofthecongresscentre.Theareawillbeclearlysignpostedfromtheregistrationarea.
TechnicalInstructions:•PostersmustbepreparedinPortraitstyle.•PleaseDONOTpreparealandscapeposter•Thedimensionsshouldbe100cmhighby70cmwide•Postersshouldbeattachedtotheboardswithstickers,whichyouwillbesuppliedtotheorganizers.•PostersessionschedulePosterswillbedisplayedandpresentedinsession.
Pleaseplantobeatyourposterandavailabletoanswerquestionsfromdelegatesatthetimeofyourassignedpostersession.PosterswillbedisplayedaccordingtothePOSTERnumbersgivenbytheorganizersandwillbegroupedbysubtopic.
Young Researchers ForumTheYoungResearchersForumoffersyoungresearchersthepossibilitytomeetanddiscussresearchtopicsandmethodologies,shareanddevelopideas,learnfromeachotherandgainknowledgefromseniorresearchers.
YoungResearcher Sessions are organized at theMedPharmaCongress, toprovide auniqueplatform forYoung Researchers/Investigators for presenting latest research projects with an in-depth analysis. YoungInvestigators(e.g.Post-Graduatestudents,Post-doctoralfellows,Trainees,Juniorfaculty)arethefocusofthisevent.Participantsshouldbebelowtheageof33years.AllsubmissionsmustbeinEnglish.
Theprizewinningpaperswillbeconsideredforpublicationintheinternationaljournalsoncethepaperissubjectedtostandardreviewprocedures.
Forfurtherinformationpleasecontact:[email protected]
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Registration InformationHowToRegister
Website:http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific//registration.php
Registration Fees• Earlyregistrationfee:$799
• (SAVE$100.00—DEADLINE:May25,2017)
• Regularregistrationfee:$899
• SAVE$100.00—February28,2017throughJune27,2017)
• Lateregistrationfee:$999
• GroupDiscount:Registerthreeormoreattendeesandreceive$50.00offperperson
• StudentRegistration:$249
• YoungResearchersForumFee:399$
Cancellation PolicyCancellationsmustbereceivedinwriting60dayspriortothemeetingandaresubjecttoa$100processingfee.RefundswillnotbegrantedafterApril03,2017,norwilltheybegivenforno-shows.Pleaseemailcancellationstobiosimilarsasia@pharmaceuticalconferences.org
AccommodationsDoubleTreebyHiltonBeijing168GuangAnMenWaiAvenueXiChengDistrict,Beijing100055China
Tomakereservationsandensurethatyouwillhaveahotelroomatthesamelocationastheconference,pleasechooseyourpackageandregisterathttp://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific//registration.php
PaymentsWeacceptVisa,MasterCard,AmericanExpressandchecks.Ifpayingbycreditcard,pleaseutilizeouronlineregistrationsitelocatedathttp://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific//registration.phpIfyouwishtopaybycheck,pleasecontactbiosimilarsasia@pharmaceuticalconferences.orgFormoreinformation:Questions?Contact1(800)2166499orinquiries:[email protected]://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific//
Stay Connected Before, During and After the Event!
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Day1:August10,2017OpeningCeremony
ConferenceSouvenirLaunchNewPerspectivefrontiersintheareaofBiologicsandBiosimilarsKeynoteForum(&ExhibitionsFullday)(PaneldiscussionsandReviews)CoffeeBreak:Networking&RefreshmentsGroupPhoto
SpeakerForumSessionsChair’sIntroductionTrack1:LatestBiosimilarsinAsianScenarioTrack2:Biosimilars-Hatch-WaxmanAct&BPCIActTrack3:ChallengesinDevelopingBiosimilarsTrack4:BiosimilarsResearchPipelineTrack5:CurrentDevelopmentsinTheFieldofBiosimilarsPaneldiscussionsandReviews
LunchBreakYoungResearchForum(PaneldiscussionsandReviews)CoffeeBreak:Networking&RefreshmentsB2BMeetingsCertificatesFelicitationbytheorganizingCommittee
Day3:August12,2017Introduction
KeynoteForum(&ExhibitionsFullday)(PaneldiscussionsandReviews)CoffeeBreak:Networking&Refreshments
SpeakerForumSessionsChair’sIntroductionTrack11:BiosimilarsAnalyticalStrategiesTrack12:EmergingBiosimilarsinTherapeuticsTrack13:ClinicalStudiesonBiosimilarsTrack14:BCS&IVIVCBasedBiowaiversTrack15:EntrepreneursInvestmentMeetPaneldiscussionsandReviewsYoungResearchForum(PaneldiscussionsandReviews)
LunchbreakSpeakerSessions(Cont…)PosterSessionsEvaluationbytheCommitteeRefreshmentsAwardCeremonyFelicitationofthebestposterawards
ClosingCeremony
Day2:August11,2017Introduction
KeynoteForum(&ExhibitionsFullday)(PaneldiscussionsandReviews)CoffeeBreak:Networking&Refreshments
SpeakerForumSessionsChair’sIntroductionTrack6:PharmacovigilanceofBiosimilarsTrack7:EmergingTrendsinBiosimilarsTrack8:BiosimilarsMarket-Challenges&ProspectsTrack9:CostAnalysisofBiosimilarsTrack10:GlobalizationofBiosimilarsPaneldiscussionsandReviews
LunchBreakYoungResearchForum(PaneldiscussionsandReviews)CoffeeBreak:Networking&RefreshmentsB2BMeetingsCertificatesFelicitationbytheorganizingCommittee
Program
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Glimpses of Biosimilars 2016
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Media Partners @ Asian Biosimilars 2017
conferenceseries.com Asian Biosimilars 2017conferenceseries.com
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/
Plan your Trip to Beijing7 UNESCO World Heritage Sites
Forbidden City Grand Canal
Great Wall Ming Tombs
Summer Palace Temple of Heaven
Zhoukoudian Forbidden City
Contact Detailshttp://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific
Submit your abstract online at: http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/abstract-submis-
sion.phpRegister online:
http://biosimilars-biologics.pharmaceuticalconferences.com/asiapacific/registration.php
About BeijingBeijing (formerly Romanized as Peking) is the capital of the People’s Republic of China and the world’s third most populous city proper. It is also one of the world’s most populous capital cities. Beijing is the second largest Chinese city by urban population after Shanghai and is the nation’s political, cultural, and educational center. It is home to the headquarters of most of China’s largest state-owned companies, and is a major hub for the national highway, expressway, railway, and high-speed rail networks. The Beijing Capi-tal International Airport is the second busiest in the world by passenger traffic. The city’s subway network is among the longest and busiest in the world. The city is renowned for its opulent palaces, temples, parks, gardens, tombs, walls and gates, and its art treasures and universities have made it a center of culture and art in China.
Beijing has seven UNESCO World Heritage Sites – the Forbidden City, Temple of Heaven, Summer Pal-ace, Ming Tombs, Zhoukoudian, as well as parts of the Great Wall and the Grand Canal. Beijing hosted the 2008 Summer Olympics and was chosen to host the 2022 Winter Olympics, which will make it the first city to ever host both events.
Beijing’s primary airport is the Beijing Capital International Airport (IATA: PEK) about 20 kilometers (12 mi) northeast of the city center. The airport is the second busiest airport in the world after Hartsfield-Jackson Atlanta International Airport. After renovations for the 2008 Olympics, the airport now boasts three terminals, with Terminal 3 being one of the largest in the world. Most domestic and nearly all inter-national flights arrive at and depart from Capital Airport. It is the main hub for Air China and a hub for China Southern and Hainan Airlines. The airport links Beijing with almost every other Chinese city with regular air passenger service.